First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury - Concepedia

Concepedia

Publication | Closed Access

First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury

202

Citations

27

References

2018

Year

Klaus Kucher, Donald R. Johns, Doris Maier, Rainer Abel, Andreas Badke, Hagen Baron, Roland Thietje, Steven Casha, Renate Ch. Meindl, Baltazar Gomez‐Mancilla,

Neurorehabilitation and neural repair

Abstract

ATI335 was well tolerated in humans; efficacy trials using intrathecal antibody administration may be considered in acute SCI.

References

	Year	Citations

Page 1